a neurotechnology company developing scalable and minimally invasive brain-computer interfaces (BCIs)
Neurosoft Bioelectronics has raised €6.5M across 1 funding round from 4 investors, most recently a Seed round in May 2026. Based in Zurich, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-05-20 | Seed | €6.5M |
| Connecticut Innovations,IAG Capital Partners,Protocol Labs,Skybound Venture Capital |
| View deal → |
